BlackRock, Inc. 13D and 13G filings for Boston Scientific Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
113,006,671 7.600% |
-14,029,994 (-11.04%) |
Filing |
| 2024-01-25 1:48 pm Sale |
2023-12-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
127,036,665 8.700% |
-10,765,981 (-7.81%) |
Filing |
| 2023-02-14 11:31 am Sale |
2022-12-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
137,802,646 9.600% |
-2,313,619 (-1.65%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
140,116,265 9.800% |
12,198,610 (+9.54%) |
Filing |
| 2022-02-08 5:12 pm Sale |
2021-12-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
127,917,655 9.000% |
-8,044,462 (-5.92%) |
Filing |
| 2021-02-05 08:03 am Purchase |
2020-12-31 | 13G | Boston Scientific Corporation BSX |
BlackRock Inc. BLK |
135,962,117 9.500% |
34,358,286 (+33.82%) |
Filing |